| Autor: |
Awada H; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Durmaz A; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Kewan T; Yale Cancer Center, New Haven, CT, USA., Ullah F; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Dima D; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Awada H; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Pagliuca S; Department of Clinical Hematology, CHRU de Nancy, Nancy, France., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Gurnari C; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Visconte V; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org. |
Full text from SpringerLink